Scholars in Diagnostic Excellence

The National Academy of Medicine (NAM) Scholars in Diagnostic Excellence is a collaborative program designed to develop a cadre of leaders who can drive implementation of national strategies to raise awareness of diagnosis in medicine, support diagnostic excellence, and reduce diagnostic errors.

The program supports participation of up to 6-8 scholars in a one-year, part-time remote experience that enhances their knowledge and skills in diagnostic quality and safety, and accelerates their career development as national leaders in the field. Awardees benefit from a structured online curriculum, cohort learning activities, professional networking and mentorship opportunities, and a $35,000 grant with an additional $5,000 domestic travel funds.

Now in its fifth year, NAM Scholars have presented at national meetings, received academic promotions, and other grants in diagnostic quality and safety.

2026 Call for Applications

The Call for Applications for the 2026-2027 class of NAM Scholars will open January 5, 2026. Applications will be due in March 2, 2026. Other key dates for prospective applicants are listed below.
Learn more and apply

Key Dates

Applicant Info Session #1

January 8, 2026 at 3:00 pm ET

Applicant Info Session #2

January 21, 2026 at 1:00 pm ET

Applicant Info Session #3

February 2, 2026 at 2:00 pm ET

Applicant Q&A Session

February 20, 2026 at 11:00 am ET

Applications Due

March 2 2026 at 3:00 pm ET

Audience: 

This program supports individuals with a focus on diagnosis-related work, including but not limited to: 

  • Physicians and advanced practice clinicians 
  • Quality experts, informaticians, and researchers 

Strong preference is given to candidates whose proposed program objectives advance specific recommendations of the 2015 National Academies of Sciences, Engineering, and Medicine consensus report, Improving Diagnosis in Health Care, when applicable.

Value: 

Investing in national diagnostic leaders increases the integrity and visibility of diagnostic excellence, and helps to build future diagnostic programs, faculty, and mentors. The program is a part of CMSS’ commitment to career development of emerging leaders, and to shared learning and collaboration among specialty societies.  

Acknowledgement

This program is funded by the Gordon and Betty Moore Foundation.

Gordon and Betty Moore Foundation
Call for Applications open on January 5, 2026!

Contact

Julia Peterson, CMSS COO  

This is an incredible program hosted by a wonderful community of brilliant people, and both the curriculum and networking opportunities offered by the program are built with deep intentionality towards helping you grow the impact of your work. 
I can’t endorse this program strongly enough; if you have an interest in diagnostic excellence, you should absolutely apply.
-Akshar Abbott, MD 
Staff Ophthalmologist, Veterans Affairs VISN 23 Clinical Resource Hub 
Akshar Abbott MD

2025 NAM Scholars in Diagnostic Excellence

  • Emily Abdoler, MD, MAEd

    Clinical Associate Professor of Medicine, Department of Medicine, Division of Infectious Diseases, University of Michigan Medical School/Veterans Affairs Ann Arbor Healthcare System, Ann Arbor
    “REFLECT: Reflective Exercises for Learning diagnosis while Engaged in Clinical Training”
  • Bubu A. Banini, MD, PhD

    Assistant Professor of Medicine, Section of Digestive Diseases, Yale School of Medicine/Yale New Haven Health System, New Haven, Conn
    “Improving Diagnosis of Steatotic Liver Diseases through an Artificial Intelligence (AI)-Based Practical and Scalable Approach”
  • Andrea Bradford, PhD

    Associate Professor, Department of Medicine, Baylor College of Medicine, Houston
    “Implementing Strategies for Achieving Diagnostic Excellence in Mental Health”
  • Nina Gold, MD, MBI

    Director of Prenatal Medical Genetics, Department of Pediatrics, Massachusetts General Hospital, Boston
    “Identification of Undiagnosed Adults at Risk for Treatable Genetic Disorders”
  • Katherine E. Goodman, JD, PhD

    Assistant Professor, Departments of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore
    “Unlocking’ Patient Symptoms with Generative AI to Promote Diagnostic Excellence”
  • Snigdha Jain, MD, MHS*

    Assistant Professor, Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn
    “Improving Diagnostic Decision-Making for Weaning Sedation and Ventilator Support in Critically Ill Older Adults: An Electronic-Health Record Based Approach”
  • Aparna Kulkarni, MBBS, MSc

    Director of Quality Improvement and Outcomes, Heart Center at Cohen Children’s Medical Center at Northwell Health; and associate professor of pediatrics, Donald and Barbara Zucker School of Medicine, New Hyde Park, N.Y.
    “Comprehensive Needs Identification and Enhanced Care Coordination to Support Access and Achieve Diagnostic Excellence in Echocardiogram Assessments of Fetuses with Congenital Heart Disease”
  • Freddy T. Nguyen, MD, PhD

    Director of MIT Catalyst Scholars Program, Office of Innovation and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge
    “Developing a Patient-Centered Framework to Guide Medical Diagnostic Technology Development”
  • Claire O’Hanlon, PhD, MPP

    Policy Researcher, Department of Behavioral and Policy Sciences, RAND Corp., Santa Monica, Calif.
    “Understanding Patient Delays in Cancer Diagnosis”
  • Lauren M. Shapiro, MD, MS

    Assistant Professor, Department of Orthopedic Surgery, University of California, San Francisco
    “Minimizing Diagnostic and Treatment Delays in Wrist Fracture Care: A Multicenter Mixed-Methods Approach”
  • R. Andrew Taylor, MD, MHS

    Vice Chair for Research and Innovation, and Professor, Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville
    “Bringing Diagnostic Quality Evaluation in the Emergency Department to Scale Through Artificial Intelligence”

Additional Information

Our partnership with NAM enables CMSS to annually support a remarkable cohort of scholars in diagnostic excellence across a wide range of specialties.

– Helen Burstin, MD, MPH, MACP
CMSS Chief Executive Officer

Search the CMSS website